JP Morgan Chase’s Axonics, Inc. Common Stock AXNX Stock Holding History

JP Morgan Chase’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$56K	–	7106
2021 Q4	$56K	Sell	1,000 -19,000	-95%	-$1.16M	﹤0.01%	5902
2021 Q3	$1.3M	Buy	+20,000	New	+$1.36M	﹤0.01%	4111

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's AXNX Position: Q4 2024 in Review

JP Morgan Chase sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 657,206 shares — an estimated $45.7M sold.

JP Morgan Chase first reported a position in AXNX in Q4 2018 and held it in 24 quarters. The position peaked at $45.7M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

JP Morgan Chase reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
JP Morgan Chase sold 657,206 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $45.7M.
JP Morgan Chase first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
JP Morgan Chase's Axonics, Inc. Common Stock position peaked at $45.7M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.